Gerussi, Alessio

Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies. [electronic resource] - Annals of hepatology - 5-16 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1665-2681

10.1016/j.aohep.2019.09.009 doi


Abatacept--therapeutic use
Anti-Bacterial Agents--therapeutic use
Azetidines--therapeutic use
Benzothiazoles--therapeutic use
Bezafibrate--therapeutic use
Chalcones--therapeutic use
Chenodeoxycholic Acid--analogs & derivatives
Cholagogues and Choleretics--therapeutic use
Cholangitis, Sclerosing--drug therapy
Fecal Microbiota Transplantation
Fibroblast Growth Factors--analogs & derivatives
Gastrointestinal Microbiome
Humans
Immunologic Factors--therapeutic use
Isoxazoles--therapeutic use
Janus Kinase Inhibitors--therapeutic use
Liver Cirrhosis, Biliary--drug therapy
Peroxisome Proliferator-Activated Receptors--agonists
Propionates--therapeutic use
Purines--therapeutic use
Pyrazoles--therapeutic use
Pyrazolones--therapeutic use
Pyridones--therapeutic use
Receptors, Cytoplasmic and Nuclear--agonists
Steroids--therapeutic use
Sulfonamides--therapeutic use
Tretinoin--therapeutic use
Ursodeoxycholic Acid--therapeutic use
Ustekinumab--therapeutic use